Friday, June 20th, 2025
Stock Profile: CMPS

COMPASS Pathways plc (CMPS)

Market: NASD | Currency: USD

Address: 33 Broadwick Street

COMPASS Pathways plc operates as a mental health care company in the United Kingdom and the United States. It develops COMP360, a psilocybin therapy that is in Phase III clinical trials for the treatment of treatment-resistant depression; and is in Phase II clinical trials for the treatment of post-traumatic stress disorder and anorexia nervosa. The company was formerly known as COMPASS Rx Limited and changed its name to COMPASS Pathways plc in August 2020. COMPASS Pathways plc was incorporated in 2020 and is headquartered in London, the United Kingdom.




📈 COMPASS Pathways plc Historical Chart






📊 Statistics





💰 Dividend History


No dividend history available.



📅 Earnings & EPS History for COMPASS Pathways plc


DateReported EPS
2026-02-25 (estimated upcoming)-
2025-10-29 (estimated upcoming)-
2025-10-28 (estimated upcoming)-
2025-07-30 (estimated upcoming)-
2025-07-29 (estimated upcoming)-
2025-05-06-
2025-05-05-
2025-02-27-0.63
2025-02-25-
2024-10-31-0.56
2024-08-01-0.56
2024-07-31-0.56
2024-05-08-0.55
2024-05-07-0.55
2024-02-29-0.53
2024-02-28-0.53
2023-11-02-0.67
2023-11-01-0.67
2023-08-03-0.62
2023-08-02-0.62
2023-05-11-0.57
2023-05-10-0.57
2023-02-28-0.73
2023-02-27-0.73
2022-11-03-0.43
2022-11-02-0.43
2022-08-04-0.5
2022-08-03-0.5
2022-05-10-0.5
2022-05-09-0.5
2022-02-24-0.61
2022-02-23-0.61
2021-11-09-0.38
2021-11-08-0.38
2021-08-11-0.44
2021-08-10-0.44
2021-05-13-0.35
2021-05-12-0.35
2021-03-09-0.52
2021-03-08-0.52
2020-11-12-1
2020-11-11-1
2020-09-21-
2020-09-20-




📰 Related News & Research


No related articles found for "compass pathways".